Dr. Todd is a Scientific Advisor to Genesis Bioventures and serves as Chairman of the Genesis Bioventures' Clinical Advisory Board. Dr. Todd received his medical training in Calgary, Alberta and currently maintains a general surgical practice at the Peace Arch Hospital in White Rock, British Columbia, specializing in the care of breast cancer patients. Dr. Todd served as Chief of Surgery at the Peace Arch Hospital for nine years and has been instrumental in establishing effective, thorough management of breast cancer patients, including award winning community support programs. Dr. Todd previously conducted studies with Genesis Bioventures to demonstrate the value of mammastatin and found that the naturally occurring protein regulates cell growth of breast tissue and appears to halt the growth of malignancies that arise from breast tissue. Dr. Todd received Health Canada approval to administer the mammastatin protein as a therapeutic to treat seven palliative women who were dying of breast cancer and found a significant remission being demonstrated in several patients. This research led Dr. Todd to enter the field of biomedical research and he subsequently co-founded ProtoKinetix, Inc., a public biotech company of which he currently serves as President and Chief Executive Officer. |